Companies /Real Estate
Ventas Inc
NYSE: VTR Reit - Healthcare Facilities
$86.49
▲ $1.98 (+2.34%) today
Markets closed · 1:53am ET

Ventas (VTR) Q1 2025 Earnings

Reported Apr 30, 2025, 4:33pm ET · SEC source
$0.84
Beat +0.00%
EPS · est. $0.00
$1.4B
Beat +3.25%
Revenue · est. $1.3B
−10.2%
Trailing market
VTR vs S&P since report
6 quarters
Consecutive EPS beats

How Did VTR Stock React to Q1 2025 Earnings?

% change · around the report
−6%−3%0Apr 30May 1report 4:33pm ETearnings+0.2%−6.5%
−6%−3%0Apr 30May 1earnings+0.2%−6.5%
VTR −6.5%S&P 500 +0.2%
−6%−3%0Apr 30May 1report 4:33pm ETearnings+0.5%−6.5%
−6%−3%0Apr 30May 1earnings+0.5%−6.5%
VTR −6.5%NASDAQ +0.5%
−6%−3%0Apr 29May 8report 4:33pm ETearnings+1.2%−6.4%
−6%−3%0Apr 29May 8earnings+1.2%−6.4%
VTR −6.4%S&P 500 +1.2%
−6%−3%0+3%Apr 29May 8report 4:33pm ETearnings+1.7%−6.4%
−6%−3%0+3%Apr 29May 8earnings+1.7%−6.4%
VTR −6.4%NASDAQ +1.7%
−6.48%
Day of report
+1.56%
Next session
+0.06%
One week
−3.49%
30 days

S&P 500 over the same 30 days: +6.74%.

Did VTR Beat Earnings? Q1 2025 Results

Ventas posted a strong first quarter of 2025, with total revenues climbing 13.2% year-over-year to $1.36 billion, beating consensus estimates of $1.32 billion by 3.25%, as the healthcare REIT continued to capitalize on what CEO Debra Cafaro has called an "unprecedented multiyear growth opportunity" in senior housing. Normalized FFO came in at $0.84 per share, reflecting approximately 8% year-over-year growth, while net income attributable to common stockholders turned positive at $0.10 per diluted share, compared to a loss of $0.04 in the year-ago period. The primary engine behind the beat was the senior housing operating portfolio, where same-store cash NOI surged 13.6% year-over-year on 290 basis points of occupancy expansion and RevPOR growth of 3.8%. Ventas also raised its full-year senior housing investment target to $1.50 billion from $1.00 billion, having already closed roughly $900.00 million in acquisitions, while reaffirming its full-year Normalized FFO guidance of $3.35 to $3.46 per share, representing 5-8% year-over-year growth.

Key Takeaways
  • SHOP same-store cash NOI grew 13.6% year-over-year driven by 7.4% revenue growth
  • SHOP same-store average occupancy grew 290 basis points year-over-year
  • U.S. SHOP average occupancy growth of 330 basis points year-over-year
  • RevPOR growth of 3.8% year-over-year (5.0% adjusted for leap year impact)
  • SHOP NOI margin growth of 150 basis points
  • Total Company NOI year-over-year growth of approximately 13%
  • Total Company Same-Store Cash NOI year-over-year growth of approximately 7%

“Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio (SHOP), which powered our first quarter results.”

Ventas CEO, on the earnings call

What Was Ventas's Outlook in Q1 2025?

Ventas reaffirmed its full-year 2025 guidance with Normalized FFO per share of $3.35-$3.46 (midpoint $3.41), representing 5-8% year-over-year growth. Attributable Net Income per share is expected at $0.42-$0.53. The company increased its 2025 senior housing investment volume guidance to $1.5 billion from $1 billion, with incremental investments expected to be second-half weighted and funded primarily with existing unsettled forward equity commitments and disposition proceeds. Net disposition proceeds are expected at approximately $200 million. Full year weighted average diluted share count increased from 456 million to 460 million. Net interest expense is expected to increase approximately $32 million year-over-year due to refinancing maturing debt at higher rates and lower cash balances.

VTR YoY Financials

Q1 2025 vs Q1 2024 · SEC filings Q1 2024 Q1 2025
$0$400.0M$800.0M$1.2B$1.2B$1.4BRevenue$9.0M$48.4MNet Income
$0$400.0M$800.0M$1.2BRevenueNet Income
VTR income statement, Q1 2025 versus Q1 2024
Metric Q1 2025 Q1 2024 Year over year
Revenue $1.4B $1.2B +13.2%
Net Income $48.4M $9.0M +437.9%

VTR Revenue by Segment

Senior Housing Operating Portfolio (SHOP)
Outpatient Medical and Research (OM&R)
Triple-Net Leased Properties (NNN)

Figures from SEC filings and company reports. Not investment advice.